Document is current
Any future updates will be listed below
-
Authors
Scarfò, Lydia
Chatzikonstantinou, Thomas
Rigolin, Gian Matteo
Quaresmini, Giulia
Motta, Marina
Vitale, Candida
Garcia-Marco, Jose Antonio https://orcid.org/0000-0002-8993-5982
Hernández-Rivas, José Ángel https://orcid.org/0000-0003-4550-757X
Mirás, Fatima
Baile, Mónica
Marquet, Juan
Niemann, Carsten U. https://orcid.org/0000-0001-9880-5242
Reda, Gianluigi
Munir, Talha
Gimeno, Eva
Marchetti, Monia https://orcid.org/0000-0001-7615-0572
Quaglia, Francesca Maria
Varettoni, Marzia
Delgado, Julio
Iyengar, Sunil
Janssens, Ann
Marasca, Roberto
Ferrari, Angela
Cuéllar-García, Carolina https://orcid.org/0000-0002-1475-5143
Itchaki, Gilad
Špaček, Martin
De Paoli, Lorenzo
Laurenti, Luca
Levin, Mark-David
Lista, Enrico
Mauro, Francesca R.
Šimkovič, Martin
Van Der Spek, Ellen
Vandenberghe, Elisabeth
Trentin, Livio https://orcid.org/0000-0003-1222-6149
Wasik-Szczepanek, Ewa
Ruchlemer, Rosa
Bron, Dominique
De Paolis, Maria Rosaria
Del Poeta, Giovanni
Farina, Lucia
Foglietta, Myriam
Gentile, Massimo
Herishanu, Yair
Herold, Tobias https://orcid.org/0000-0002-9615-9432
Jaksic, Ozren
Kater, Arnon P.
Kersting, Sabina
Malerba, Lara
Orsucci, Lorella
Popov, Viola Maria https://orcid.org/0000-0002-1200-379X
Sportoletti, Paolo https://orcid.org/0000-0002-5630-9862
Yassin, Mohamed
Pocali, Barbara
Barna, Gabor
Chiarenza, Annalisa
dos Santos, Gimena https://orcid.org/0000-0002-9337-1833
Nikitin, Eugene
Andres, Martin https://orcid.org/0000-0001-9891-2988
Dimou, Maria https://orcid.org/0000-0001-8197-9895
Doubek, Michael https://orcid.org/0000-0002-1269-6282
Enrico, Alicia
Hakobyan, Yervand
Kalashnikova, Olga
Ortiz Pareja, Macarena
Papaioannou, Maria
Rossi, Davide
Shah, Nimish
Shrestha, Amit
Stanca, Oana
Stavroyianni, Niki
Strugov, Vladimir
Tam, Constantine
Zdrenghea, Mihnea
Coscia, Marta
Stamatopoulos, Kostas
Rossi, Giuseppe
Rambaldi, Alessandro https://orcid.org/0000-0002-3739-7502
Montserrat, Emili’
Foà, Robin https://orcid.org/0000-0002-5021-3026
Cuneo, Antonio
Ghia, Paolo https://orcid.org/0000-0003-3750-7342
- License Information
-
More Information
Article History
Received: 13 June 2020
Revised: 21 June 2020
Accepted: 30 June 2020
First Online: 9 July 2020
Compliance with ethical standards
:
: LS received honoraria from AbbVie, AstraZeneca, Gilead, Janssen. GMR received honoraria from Abbvie, Gliead, and Janssen and research funding from Gilead. MaMo received onoraria from Janssen and Roche. CV received consultancy fees from Janssen, outside the submitted work. JAG received honoraria from AbbVie, AstraZeneca, Gilead, Janssen, and Roche. Research funding from AbbVie, Gilead, and Janssen. JAH received honoraria for lectures and Advisory Boards from Janssen, Abbvie, Roche, Gilead, AstraZeneca. CUN received research support and/or honoraria from Abbvie, AstraZeneca, CSL Behring, Janssen, and Sunesis. GR received honoraria from AbbVie, Gilead, Janssen. EG received travel grants, honoraria as consultant and/or speaker bureau from Janssen, Abbvie, Roche, and Gilead. MoMo received consultant fees from Gilead. MV received honoraria for Advisory boards from Janssen and Roche. SI received Honoraria Janssen and Gilead. AJ received travel grants, speaker fees or consultancies: Amgen, Abbvie, Celgene, Janssen, Gilead, Novartis, Sanofi-Genzyme, Roche. AF received honoraria from AbbVie. MaSp received honoraria from AbbVie, Gilead, and Janssen. ML received honoraria for Advisory board and travel compensation from Janssen, Abbvie, and Roche. EVDS received compensation for teaching activities from Amgen. EV received travel grants from Abbvie, Gilead, Jannsenns, and Roche, research grants from Abbvie, Gilead, and Roche. LF received honoraria from AbbVie, Janssen (Advisory role or Lecturer). MF received honoraria from Abbvie, Janssen, Gilead. YH received honoraria from AbbVie, AstraZeneca, Janssen, Medison, Sanofi, and Roche. OJ received Honoraria from Abbvie, Janssen, and Roche. APK received research support: Abbvie, Janssen, Roche/Genentech, AstraZeneca; Adboard: Abbvie, Janssen, Roche/Genentech, AstraZeneca; speakersfee: Janssen, AstraZeneca, Abbvie. SK received Travel grant from Celgene, research funding from Janssen, Abbvie. MA received travel support and advisory boards from AbbVie, Janssen-Cilag, Celgene, Novartis. DR received honoraria from Abbvie, AstraZeneca, Gilead, Janssen, Loxo, and Verastem, and research grants from Abbvie, AstraZeneca, Cellestia, Gilead, Janssen. NS received consulting fees from AbbVie, Roche, Janssen. CT received honorarium and research funding from Janssen, Beigene, and Abbvie. MC received research funding from Janssen and Karyopharm Therapeutics, and personal fees from Janssen, Gilead, Abbvie, and Shire, outside the submitted work. KS received honoraria from Abbvie, Acerta/AstraZeneca, Gilead, Janssen, and research funding from Abbvie, Gilead, Janssen. AC received honoraria from AbbVie, AstraZeneca, Gilead, Janssen. RF received honoraria from Abbvie, Gliead, Janssen, AstraZeneca, Amgen, Incyte, Novartis. PG received honoraria from AbbVie, Adaptive, Acerta/AstraZeneca, ArQule, BioGene, Dynamo, Gilead, Janssen, MEI, Sunesis, and Research funding from AbbVie, Gilead, Janssen, Sunesis. TC, GQ, FM, MB, JM, TM, FMQ, JD, RM, CC, GI, LDP, LL, EL, FRM, MaSi, LT, EW, RR, DB, MRDP, GDP, MG, TH, LM, LO VMP, PS, MY, BP, GB, AC, GdS, EN, MaDi, MiDo, AE, YH, OK, MOP, MP, AS, OA, NS, VS, MZ, GR, AR, EM have no conflict of interest to disclose.
Free to read: This content has been made available to all.
